Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04201821 · ClinicalTrials.gov registry record · Phase 1
Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women
A Phase 1 study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT04201821: Clinical Trial Phase 1 study, sponsored by University of Pennsylvania.
NCT04201821 is a Phase 1 study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04201821, a Phase 1 study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
Open label pilot study assessing FMT to treat fecal incontinence in women 50 years of age and older.
Interventions
- BIOLOGICAL fecal microbial transplantation (FMT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-01-14 |
| Est. Completion | 2023-01-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04201821
The ClinicalTrials.gov registry entry for NCT04201821 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fecal microbial transplantation (FMT) is the first listed.
NCT04201821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04201821 about?
NCT04201821 is a clinical study titled "Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women". Open label pilot study assessing FMT to treat fecal incontinence in women 50 years of age and older.
What is the current status of trial NCT04201821?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2021-01-14. Estimated completion is 2023-01-18.
What interventions are being tested in trial NCT04201821?
The interventions under investigation include: fecal microbial transplantation (FMT) (BIOLOGICAL).
Who is sponsoring clinical trial NCT04201821?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.